Eric J. Loumeau is CLO at ANAPTYSBIO, INC (ANAB). They have made 9 open-market trades across 1 company since 2007, most recently 2026-02-11.
CIK 0001239648
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ANAB | 22,835 | $1.1M |
| OTIC | 1,206 | $93 |
| HEPH | 8,809 | — |
| Total | $1.1M |
Shares reported on the most recent Form 4, priced at the 2026-02-13 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANAB | SELL | 2026-02-11 | 2026-02-13 | $54.00 | $540K | +5.7% | +22.0% | +17.1% |
| ANAB | SELL | 2026-01-08 | 2026-01-09 | $44.71 | $99K | +6.3% | +12.1% | +53.9% |
| ANAB | SELL | 2026-01-07 | 2026-01-08 | $45.56 | $439K | +9.2% | +16.8% | +53.3% |
| ANAB | SELL | 2026-01-05 | 2026-01-06 | $43.26 | $129K | +0.1% | +4.9% | +36.8% |
| ANAB | SELL · 10b5-1 | 2025-12-22 | 2025-12-23 | $51.00 | $510K | -12.2% | -5.3% | +25.4% |
| ANAB | SELL · 10b5-1 | 2025-12-16 | 2025-12-18 | $45.20 | $1.6M | +1.8% | -2.9% | +35.9% |
| ANAB | SELL · 10b5-1 | 2025-09-30 | 2025-10-01 | $29.00 | $239K | +1.0% | +13.8% | +50.0% |
| ANAB | SELL · 10b5-1 | 2024-09-16 | 2024-09-17 | $39.40 | $985K | -15.0% | -6.2% | -55.6% |
| ANAB | SELL · 10b5-1 | 2024-02-16 | 2024-02-21 | $25.00 | $125K | +2.7% | -14.9% | -6.0% |
| ANAB | SELL | 2024-01-08 | 2024-01-09 | $21.81 | $101K | +3.9% | +1.2% | -9.5% |
| ANAB | SELL · 10b5-1 | 2023-11-22 | 2023-11-27 | $14.19 | $13K | +18.1% | +57.3% | +90.4% |
| ANAB | SELL | 2023-09-14 | 2023-09-18 | $19.35 | $192K | -6.1% | -3.5% | +2.5% |
| ANAB | SELL · 10b5-1 | 2022-08-08 | 2022-08-09 | $25.00 | $13K | +6.7% | +12.6% | +23.0% |
| ANAB | SELL | 2022-06-08 | 2022-06-10 | $24.00 | $60K | +6.4% | -9.1% | +25.2% |
| ANAB | SELL · 10b5-1 | 2022-05-18 | 2022-05-20 | $20.50 | $23K | -10.3% | +7.0% | +19.1% |
| ANAB | SELL | 2021-11-04 | 2021-11-05 | $35.00 | $175K | -14.1% | -17.2% | -18.7% |
| ANAB | SELL | 2021-02-12 | 2021-02-12 | $35.00 | $350K | -26.8% | -44.2% | -26.8% |
| OTIC | SELL · 10b5-1 | 2017-06-23 | 2017-06-27 | $18.59 | $65K | +0.0% | +2.7% | -82.3% |
| HEPH | SELL · 10b5-1 | 2007-02-14 | 2007-02-15 | $5.50 | $5K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.